A Randomised, Double-blind, Placebo Controlled Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Dry Powder Doses of GSK159802 in Healthy Male Subjects and Asthmatics
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2016
At a glance
- Drugs GSK 159802 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 12 Nov 2006 New trial record.